台股 » 共信-KY » 個股財報 » 每月營收

共信-KY

(6617)
可現股當沖
  • 股價
    78.8
  • 漲跌
    ▼1.6
  • 漲幅
    -1.99%
  • 成交量
    122
  • 產業
    上櫃 生技醫療類股 ▼0.48%
  • 本地時間:13:30

    41人加入追蹤

    立即追蹤

共信-KY (6617) 財務報表-每月營收
月營收報表

因應IFRSs國際會計準則,本報表在2013年以前為「個別營收」,2013年以後為「合併營收」。

共信-KY (6617) 月營收分析比較圖

共信-KY (6617) 月營收報表

年度/月份營業收入(單位:千元)累計營業收入(單位:千元)
單月營收去年同月營收單月月增率單月年增率累計營收去年累計營收累積年增率
2025/112,5912,96138.3%-12.5%33,00429,62211.4%
2025/101,8742,735-62.9%-31.5%30,41326,66114.1%
2025/095,0502,77117.2%82.2%28,53923,92619.3%
2025/084,3103,17653.7%35.7%23,48921,15511%
2025/072,8052,7635.8%1.5%19,17917,9796.7%
2025/062,6503,7420.9%-29.2%16,37415,2167.6%
2025/052,6273,530-24.6%-25.6%13,72411,47419.6%
2025/043,4852,45725.2%41.8%11,0977,94439.7%
2025/032,7842,34613.8%18.7%7,6125,48738.7%
2025/022,4471,4402.8%69.9%4,8283,14153.7%
2025/012,3811,701-11.4%40%2,3811,70140%
2024/122,6863,875-9.3%-30.7%32,30818,93770.6%
2024/112,9612,1638.3%36.9%29,62215,06296.7%
2024/102,7352,609-1.3%4.8%26,66112,899106.7%
2024/092,7712,692-12.8%2.9%23,92610,290132.5%
2024/083,1763,03514.9%4.6%21,1557,598178.4%
2024/072,7633,434-26.2%-19.5%17,9794,563294%
2024/063,7423766%895.2%15,2161,1291247.7%
2024/053,53075343.7%368.8%11,4747531423.8%
2024/042,45704.7%0%7,94400%
2024/032,346062.9%0%5,48700%
2024/021,4400-15.3%0%3,14100%
2024/011,7010-56.1%0%1,70100%
2023/123,8751,14379.1%239%18,9371,1431556.8%
2023/112,1630-17.1%0%15,06200%
2023/102,6090-3.1%0%12,89900%
2023/092,6920-11.3%0%10,29000%
2023/083,0350-11.6%0%7,59800%
2023/073,4340813.3%0%4,56300%
2023/063760-50.1%0%1,12900%
2023/0575300%0%75300%
2023/04000%0%000%
2023/03000%0%000%
2023/02000%0%000%
2023/0100-100%0%000%
2022/121,14300%0%1,1431,1430%
共信-KY受惠肺癌新藥出貨旺 9月營收年增逾8成續寫新猷Anue鉅亨-2025/10/07
共信-KY肺癌新藥通過中國醫保雙目錄形式審查 看好助攻營收倍增Anue鉅亨-2025/08/26
〈焦點股〉共信-KY獲5000萬美元投資意向赴美進行臨床 亮燈漲停Anue鉅亨-2025/07/11
共信-KY 相關文章
共信-KY 相關影音